Related Experiment Video
Updated: Aug 18, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
Progesterone induces BRCA1 mRNA decrease, cell cycle alterations and apoptosis in the MCF7 breast cancer cell line
Yan Ansquer1, Agnès Legrand, Annie-France Bringuier
1INSERM U 481, Faculté de Médecine Xavier Bichat, 75018 Paris, France. yan.ansquer@lmr.ap-hop-paris.fr
Background:
Inherited mutations of the BRCA1 gene are responsible for hereditary breast and ovarian cancer syndrome. However, little is known of how disruption of BRCA1 functions preferentially increases cancer risk in hormone-dependent organs. We aimed to study whether BRCA1 was regulated by progesterone in the MCF7 breast cancer cell line.
Materials And Methods:
MCF7 breast cancer cells were incubated with 10(-4) or 10(-10) M progesterone for 24 or 48 hours. BRCA1 expression, proliferation and apoptosis were analysed.
Results:
10(-4) M progesterone decreased cell proliferation, cell cycle progression and induced apoptosis. In addition, BRCA1 and cyclin A mRNA decreased. In contrast, none of these effects were observed in MCF7 cells incubated with 10(-10) M progesterone.
Conclusion:
The down-regulation of BRCA1 in MCF7 cells incubated with 10(-4) M progesterone seems to be a consequence of cell cycle alterations rather than a direct effect of the hormone on BRCA1.
Insights
High-dose progesterone down-regulates BRCA1 expression in breast cancer cells, impacting cell cycle and apoptosis. This suggests BRCA1 regulation is linked to cell cycle changes, not direct hormonal effects.
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- BRCA1 gene mutations are linked to hereditary breast and ovarian cancers.
- The role of BRCA1 in hormone-dependent organ cancer risk is not fully understood.
- Investigating BRCA1 regulation by progesterone in breast cancer cells is crucial.
Purpose of the Study:
- To determine if progesterone regulates BRCA1 expression in MCF7 breast cancer cells.
- To explore the effects of different progesterone concentrations on cell behavior and BRCA1 levels.
Main Methods:
- MCF7 cells were treated with 10(-4) M or 10(-10) M progesterone for 24 or 48 hours.
- Analysis included BRCA1 expression, cell proliferation, apoptosis, and cell cycle progression.
Main Results:
- High-dose progesterone (10(-4) M) reduced cell proliferation and induced apoptosis.
- This high-dose treatment also decreased BRCA1 and cyclin A mRNA levels.
- Low-dose progesterone (10(-10) M) had no significant effects.
Conclusions:
- BRCA1 down-regulation by high-dose progesterone appears secondary to cell cycle alterations.
- The study suggests progesterone does not directly regulate BRCA1 in this context.
- Findings highlight the complex interplay between hormones, cell cycle, and BRCA1 in breast cancer.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway

